EN
HI

Kobo Biotech Share price

KOBO

HealthcareSmall

2.68

0.12 (-4.29%)
Last updated on 30 May, 2025 | 14:59 IST
BUYSELL
Today's High

2.80

Today's Low

2.66

52 Week Low

2.51

52 Week High

4.79

The current prices are delayed, login to your account for live prices

Kobo Biotech Chart

Kobo Biotech Share Key Metrics

Volume
2870.00
Market Cap
6.67 CR
LTQ@LTP
75@2.68
ATP
2.7
Var Margin
100 %
Circuit Range
2.66-2.94
Delivery %
0 %
Value
7749.00
ASM/GSM
No
Market Lot
1

Kobo Biotech Futures & Options

Data Not Found

Kobo Biotech Corporate Actions

DateAgenda
No Data Found
DateEvent TypeAgenda
No Data Found

Kobo Biotech News

No Data Found

About Kobo Biotech

NSE : 0  
BSE : 531541  
ISIN : INE881A01015  

The Company was incorporated on August 03 1993 as AvonOrganics Limited. It obtained certificate of commencementof business on July 5 1994 promoted by Mr. P.R. AgarwalMr. Rajesh Agarwal and Dr. G.S. Sidhu.The company proposes to manufacture Diketene andderivatives - Mono Methyl Acetoacetamide (MMA) and MethylAceto Acetate (MAA). Diketene is the mother chemical and isin itself not sold. The Company has entered into a Tripartite Agreement dated12th October 1994 for which the Department of IndustrialDevelopment Secretariat of Industrial Approvals Ministryof Industry has given permission vide their letter FC.IINo:90(93)/4/ILF/93 dated April 2nd 1993 with ShanghaiMachinery & Equipment Import & Export Corporation (SMEC)on behalf of Shanghai Peng Pu Chemical Works (SPCW) fortechnology transfer and with Xytel TechnologiesPartnership U S A for the co-ordination and transfer oftechnology (between the Company and SMEC).The entire production of Diketene will be converted toDerivatives. Diketene is reactive in nature and a largenumber of derivatives can be produced from it. Also theinfrastructure required for the conversion of Diketene to aderivative is a very minimal as every derivative is asingle step reaction from Diketene. Hence the companyalways has the option of changing the derivatives that areproposed to be manufactured as and when the market sodemands.

Kobo Biotech Management

NamePosition
Mr. Ajit Kamath Chairman & Non-Exe.Director
Mr. Rajendra Kaimal Non Executive Director
Dr. Sunil Pitroda Independent Director
Mr. Abhishek Buddhadev Independent Director
Ms. Urja Shah Independent Director
Read More

Kobo Biotech FAQs

The Buying Price of Kobo Biotech share is 2.68 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Kobo Biotech share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Kobo Biotech shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Kobo Biotech shares is 0. Useful to assess the stock's value relative to its book value.

To assess Kobo Biotech’s valuation compare Sector P/E, P/B which are 37.05 & 4.02 with sector averages, along with growth rates and financial metrics.

The Market Cap of Kobo Biotech is 6.67 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Kobo Biotech share price is 4.79 & 2.51. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.